MacroGenics
MGNX
#8486
Rank
โ‚น17.60 B
Marketcap
โ‚น277.08
Share price
-3.25%
Change (1 day)
46.23%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): -โ‚น4.98

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -โ‚น4.65. In 2024 the company made an earnings per share (EPS) of -โ‚น99.49 a decrease over its 2023 EPS that were of -โ‚น13.95.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น4.98-94.99%
2024-โ‚น99.49613.33%
2023-โ‚น13.95-92.31%
2022-โ‚น181.31-42.14%
2021-โ‚น313.3436.44%
2020-โ‚น229.66-21.84%
2019-โ‚น293.81-24.58%
2018-โ‚น389.58675.93%
2017-โ‚น50.21-68.05%
2016-โ‚น157.13168.25%
2015-โ‚น58.58-55%
2014-โ‚น130.173400%
2013-โ‚น3.72-108.68%
2012โ‚น42.8624.49%
2011โ‚น34.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น126.45-2,820.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,140-46,139.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,332-28,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น606.22-13,140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น679.37-14,713.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น276.15-6,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚น164.57 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA